TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · major macro event coming up
A

Agilent Technologies Inc

Healthcare · Diagnostics & Research

172.80$ +0.0% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Income Statement

Agilent Technologies Inc (A) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 1,878 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement A
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
1,688 1,658 1,573 1,578 1,701 1,681 1,668 1,738 1,861 1,798 1,835 1,878 7,372
773 750 717 723 785 782 802 824 897 852 826 836 3,411
915 908 856 855 916 899 866 914 964 946 1,009 1,042 3,961
114 128 113 127 111 113 112 111 119 117 126 123 485
593 396 380 395 361 410 454 417 428 476 465 475 1,844
507 524 493 522 508 523 566 554 521 593 610 598 2,322
408 384 363 333 408 376 300 360 443 353 399 444 1,639
22 22 20 22 32 28 29 28 27 25 25 29 106
420 403 374 343 401 367 260 366 442 364 408 444 1,658
-55 55 66 61 50 49 45 30 8.0 59 69 82 218
475 348 308 282 351 318 215 336 434 305 339 362 1,440
504 487 436 428 502 467 362 466 540 456 500 473 1,969

LTM = last twelve months (sum of the four most recent quarters).

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?